The European diabetes diagnosis, treatment and drug delivery market increased in 2015 and growth is expected to persist over the forecast period. Market growth will be driven by the growing prevalence of diabetes in Europe and technological advancements made in certain segments, particularly insulin pumps and continuous glucose monitoring (CGM). Limitations to market growth include pricing pressure due to increased competition in the test strip and pen needle segments, as well as budgetary pressure to decrease diabetes expenditure of national healthcare organizations.
Diabetes mellitus is a multifaceted disease that yields various approaches in terms of diagnosis, treatment and drug delivery. Products for maintenance and treatment of diabetes can be of high volume and low cost or of relatively low volume and high cost.
'
TABLE OF CONTENTS I
LIST OF FIGURES IV
LIST OF CHARTS VI
EXECUTIVE SUMMARY 1
EUROPEAN MARKET FOR DIABETES MONITORING, TREATMENT AND DRUG DELIVERY 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 6
MARKET DEVELOPMENTS 8
MARKETS INCLUDED 9
KEY REPORT UPDATES 10
VERSION HISTORY 10
RESEARCH METHODOLOGY 11
1.1 RESEARCH SCOPE 11
1.2 IDATA’S 9-STEP METHODOLOGY 11
Step 1: Project Initiation & Team Selection 11
Step 2: Prepare Data Systems and Perform Secondary Research 13
Step 3: Preparation for Interviews & Questionnaire Design 14
Step 4: Performing Primary Research 15
Step 5: Research Analysis: Establishing Baseline Estimates 17
Step 6: Market Forecast and Analysis 18
Step 7: Identify Strategic Opportunities 20
Step 8: Final Review and Market Release 21
Step 9: Customer Feedback and Market Monitoring 22
DISEASE OVERVIEW 23
2.1 INTRODUCTION 23
2.1.1 Types of Diabetes 23
2.1.2 Diabetes Complications 25
2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes 27
2.1.4 Signs and Symptoms 28
2.1.5 Diabetes Monitoring 29
2.1.6 Treatment 31
2.1.7 Drug Delivery Systems 33
EUROPEAN DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW 35
3.1 MARKET OVERVIEW 35
3.2 TREND ANALYSIS 43
3.3 CURRENCY EXCHANGE RATE 46
3.4 DRIVERS AND LIMITERS 47
3.4.1 Market Drivers 47
3.4.2 Market Limiters 48
3.5 COMPETITIVE MARKET SHARE ANALYSIS 52
3.6 MERGERS AND ACQUISITIONS 58
COUNTRY PROFILES 59
4.1 INTRODUCTION 59
4.1.1.1 Population 59
4.1.1.2 GDP Per Capita 59
4.1.1.3 Units 59
4.2 GERMANY 60
4.3 FRANCE 61
4.4 UNITED KINGDOM 62
4.5 ITALY 63
4.6 SPAIN 64
4.7 BENELUX 65
4.8 SCANDINAVIA 66
4.9 AUSTRIA 67
4.10 SWITZERLAND 68
4.11 PORTUGAL 69
ABBREVIATIONS 70
Chart 1 1: Diabetes Diagnosis, Treatment and Drug Delivery, Europe, 2012 – 2022 3
Chart 1 2: Diabetes Diagnosis, Treatment and Drug Delivery Market Overview, Europe, 2012 & 2022 3
Chart 3 1: Total Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe, 2012 – 2022 (€M) 41
Chart 3 2: Total Diabetes Diagnosis, Treatment and Drug Delivery Market Breakdown, Europe, 2015 42
Chart 3 3: Total Diabetes Diagnosis, Treatment and Drug Delivery Market Breakdown, Europe, 2022 42
Chart 3 4: Growth Rates by Segment, Total Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2012 – 2022 45
Chart 3 5: Leading Competitors, Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2015 57
Chart 4 1: Country Profile, Germany, 2015 60
Chart 4 2: Country Profile, France, 2015 61
Chart 4 3: Country Profile, United Kingdom, 2015 62
Chart 4 4: Country Profile, Italy, 2015 63
Chart 4 5: Country Profile, Spain, 2015 64
Chart 4 6: Country Profile, Benelux, 2015 65
Chart 4 7: Country Profile, Scandinavia, 2015 66
Chart 4 8: Country Profile, Austria, 2015 67
Chart 4 9: Country Profile, Switzerland, 2015 68
Chart 4 10: Country Profile, Portugal, 2015 69
Figure 1 1: Diabetes Diagnosis, Treatment and Drug Delivery Competitor Market Share Ranking by Segment, Europe, 2015 (1 of 2) 4
Figure 1 2: Diabetes Diagnosis, Treatment and Drug Delivery Competitor Market Share Ranking by Segment, Europe, 2015 (2 of 2) 4
Figure 1 3: Companies Researched in this Report, Europe, 2015 5
Figure 1 4: Factors Impacting the Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe (1 of 2) 6
Figure 1 5: Factors Impacting the Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe (2 of 2) 7
Figure 1 6: Recent Events in the Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2012 – 2016 8
Figure 2 1: Major Types of Diabetes and Related Pathologies, Europe, 2015 24
Figure 2 2: Risk Factors Associated with Type 1 and Type 2 Diabetes, Europe, 2015 28
Figure 2 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, Europe, 2015 29
Figure 3 1: Total Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe, 2012 – 2022 (€M) (1 of 2) 37
Figure 3 2: Total Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe, 2012 – 2022 (€M) (2 of 2) 38
Figure 3 3: Total Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe, 2012 – 2022 (US$M) (1 of 2) 39
Figure 3 4: Total Diabetes Diagnosis, Treatment and Drug Delivery Market by Segment, Europe, 2012 – 2022 (US$M) (2 of 2) 40
Figure 3 5: Growth Rates by Segment, Total Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2012 – 2022 (1 of 2) 44
Figure 3 6: Growth Rates by Segment, Total Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2012 – 2022 (2 of 2) 44
Figure 3 7: Currency Exchange Rate, 2015 46
Figure 3 8: Drivers and Limiters, Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2015 51
Figure 3 9: Leading Competitors, Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2015 (1 of 2) 55
Figure 3 10: Leading Competitors, Diabetes Diagnosis, Treatment and Drug Delivery Market, Europe, 2015 (2 of 2) 56
Novo Nordisk
Sanofi
Roche
Johnson & Johnson
Eli Lilly
Abbott
Ascensia
Becton Dickinson
Medtronic
Menarini
DexCom
Ypsomed
Insulet
Artsana
B. Braun
Terumo
Others include: Abbott, AgaMatrix, Artsana, Apollo, BBI Healthcare, B. Braun, Berger, Beurer, Boehringer Ingelheim, Cellnovo, Codan, Comfort Point, Dario Health, Elektronika, Entra Health Systems, GlucoRx, GlucoZen, Infopia, Medtronic, MED TRUST, Medisana, Menarini, Merck Serono, MSP bodmann, Neon Diagnostics, NordicInfu Care, Novalab Ibérica, Novico, Owen Mumford, Pentaferte, Roche, Sanofi, SD BIOSENSOR, SFM Medical, Smiths Medical, Spirit Healthcare, Sooil, Trividia Health, Ypsomed, etc.
